Chen Zou
No. 5 Hebin Road, Chancheng District
Foshan, 528000, China
Foshan, 528000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Uncovering biomarkers and pathways in oral squamous cell carcinoma through integrated lncRNA-mRNA regulatory network analysis.
Journal: Discover oncology
Published: November 28, 2024
Circ-ILF2 in oral squamous cell carcinoma promotes cisplatin resistance and induces M2 polarization of macrophages.
Journal: Journal of cellular and molecular medicine
Published: August 22, 2023
Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels the molecular feature of M2 macrophages of head and neck squamous cell carcinoma.
Journal: Journal of cellular and molecular medicine
Published: July 15, 2023
SP2-induced circPUM1 modulates chemoresistance and nature killer cell toxicity in oral squamous cell carcinoma.
Journal: Journal of cellular and molecular medicine
Published: May 10, 2023
The Potential Mechanism of Curcumin in Treating Oral Squamous Cell Carcinoma Based on Integrated Bioinformatic Analysis.
Journal: International journal of genomics
Published: April 30, 2023
CircMAT2B Induced by TEAD1 Aggravates the Warburg Effect and Tumorigenesis of Oral Squamous Cell Carcinoma through the miR-942-5p/HSPD1 Axis.
Journal: Journal of oncology
Published: April 19, 2022
Long non-coding RNA LINC00472 inhibits oral squamous cell carcinoma via miR-4311/GNG7 axis.
Journal: Bioengineered
Published: March 04, 2022
AM1241-Loaded Poly(ethylene glycol)-Dithiothreitol Hydrogel Repairs Cranial Bone Defects by Promoting Vascular Endothelial Growth Factor and COL-1 Expression.
Journal: Frontiers in cell and developmental biology
Published: March 03, 2022
Circular RNA mitochondrial translation optimization 1 homologue (CircMTO1) induced by zinc finger protein 460 (ZNF460) promotes oral squamous cell carcinoma progression through the microRNA miR-320a / alpha thalassemia/mental retardation, X-linked (ATRX) axis.
Journal: Bioengineered
Published: November 05, 2021
Pan-Cancer Analyses of the Tumor Microenvironment Reveal That Ubiquitin-Conjugating Enzyme E2C Might Be a Potential Immunotherapy Target.
Journal: Journal of immunology research
Published: September 21, 2021
circ_0001461 promotes oral squamous cell carcinoma progression through miR-145/TLR4/NF-κB axis.
Journal: Biochemical and biophysical research communications
Published: June 01, 2021
Last Updated: 09/26/2026